Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review
- PMID: 32911281
- DOI: 10.1016/j.semarthrit.2020.07.005
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review
Abstract
Background: Giant cell arteritis (GCA; sometimes referred to as temporal arteritis) and polymyalgia rheumatica (PMR) are common and interrelated inflammatory conditions that almost exclusively affect adults older than 50 years. There is a need for updated information on the epidemiology of these diseases.
Objective: This systematic literature review (SLR) aims to summarize current evidence regarding the global incidence and prevalence of GCA and PMR.
Methodology: A systematic search of PubMed and Google Scholar databases from their inception dates to July 30, 2019 for relevant publications was performed. Studies that reported incidence and/or prevalence estimates for GCA and/or PMR were identified. When there were multiple studies of the same population, the most recent estimates were used. Details on source populations and case validation were systematically reviewed. Results were tabulated per region in the world.
Results: Screening by 2 authors resulted in 2643 abstracts, of which 77 articles met the inclusion criteria. There were more studies on GCA compared to PMR, and more on incidence than on prevalence. Wide variations were found in study design and populations studied. Studies that included a thorough case validation tended to give lower estimates, in particular for PMR. The highest incidence per 100 000 aged ≥50 years of GCA was observed in studies from Scandinavia and the UK (14.6 to 43.6), and in Minnesota, USA (19.8 per 100 000). Corresponding estimates for Southern Europe were lower (1.1 to 11.1). Limited evidence indicates that GCA and PMR is less common in non-Caucasian populations. Prevalence estimates for PMR were ≥ 3 times higher than that of GCA in Caucasians.
Conclusion: This SLR provides up to date estimates of the occurrence of GCA and PMR in different populations around the world. The incidence of GCA is higher in populations of Northern European ancestry. Data on the epidemiology of PMR are more limited, with greater variation in incidence and prevalence estimates.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Similar articles
-
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis.Medicina (Kaunas). 2021 Apr 6;57(4):350. doi: 10.3390/medicina57040350. Medicina (Kaunas). 2021. PMID: 33917502 Free PMC article. Review.
-
Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.Semin Arthritis Rheum. 2017 Oct;47(2):253-256. doi: 10.1016/j.semarthrit.2017.04.001. Epub 2017 Apr 7. Semin Arthritis Rheum. 2017. PMID: 28551169 Free PMC article.
-
Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis.Semin Arthritis Rheum. 2022 Oct;56:152069. doi: 10.1016/j.semarthrit.2022.152069. Epub 2022 Jul 13. Semin Arthritis Rheum. 2022. PMID: 35858507
-
Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.Heart. 2016 Mar;102(5):383-9. doi: 10.1136/heartjnl-2015-308514. Epub 2016 Jan 19. Heart. 2016. PMID: 26786818 Free PMC article.
-
Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.Rheumatol Int. 2018 Apr;38(4):569-577. doi: 10.1007/s00296-017-3874-3. Epub 2017 Nov 9. Rheumatol Int. 2018. PMID: 29124397
Cited by
-
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis.Medicina (Kaunas). 2021 Apr 6;57(4):350. doi: 10.3390/medicina57040350. Medicina (Kaunas). 2021. PMID: 33917502 Free PMC article. Review.
-
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care.RMD Open. 2023 Apr;9(2):e002970. doi: 10.1136/rmdopen-2022-002970. RMD Open. 2023. PMID: 37094980 Free PMC article.
-
Giant Cell Arteritis With Sepsis-Like Symptoms in an Elderly Man: A Case Report.Cureus. 2024 May 25;16(5):e61074. doi: 10.7759/cureus.61074. eCollection 2024 May. Cureus. 2024. PMID: 38915961 Free PMC article.
-
Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.Z Rheumatol. 2024 Feb;83(Suppl 1):20-30. doi: 10.1007/s00393-022-01302-5. Epub 2023 Feb 7. Z Rheumatol. 2024. PMID: 36749363 Free PMC article.
-
Whole-Body [18F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease.Diagnostics (Basel). 2021 Nov 9;11(11):2073. doi: 10.3390/diagnostics11112073. Diagnostics (Basel). 2021. PMID: 34829421 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous